Bhringraj Extract: Regulatory & Compliance Notes

Because bhringraj (Eclipta prostrata) can be sold as a hair-and-skin cosmetic ingredient or as an oral supplement ingredient, its regulatory treatment is not one rule but several. The framework depends on the destination market and on the intended use. This note maps the main jurisdictions and the documentation a buyer should line up before shipping. It is general guidance, not legal advice — always confirm the current position for your product and market with a qualified regulatory adviser.

Two Regulatory Identities

Fix the intended use first, because it determines the entire compliance path:

• Cosmetic use — in hair oils, shampoos, serums and scalp products, bhringraj is a topical cosmetic ingredient with its own INCI name and cosmetic regulatory regime.
• Supplement / food use — in capsules, powders or beverages, it is an oral ingredient governed by supplement or food law, which is far more market-dependent.

The same extract can serve both, but the paperwork and the permitted claims are different. Declare the use up front.

European Union

For cosmetic use, bhringraj is an established ingredient with the INCI name “Eclipta Prostrata Extract”, placed on the market under Regulation (EC) 1223/2009. That means a CPNP notification and a product safety assessment before sale, with the ingredient supported by identity and safety documentation.

For food-supplement use, the position is more cautious: oral use of Eclipta prostrata in the EU may raise novel-food questions and is member-state dependent, so its supplement status must be confirmed for the specific market rather than assumed. On the import side, EU shipments require a heavy-metals and pesticide-MRL dossier, and ethylene oxide (ETO) is a key trigger — pre-testing on request is standard practice for EU-bound material.

United States

In the US, oral bhringraj is handled as a dietary supplement ingredient under DSHEA — Eclipta alba has a history of use as a botanical — manufactured under cGMP at 21 CFR 111. For topical products it appears under its cosmetic INCI name. Crucially, supplement labelling is limited to structure/function claims (for example, “supports healthy hair”); disease claims are not permitted. See our discipline notes below and our benefits & research insight for how to frame the evidence honestly.

India & Other Markets

In its home market, bhringraj is well established. As Bhringaraja, it is an official herb in the Ayurvedic Pharmacopoeia of India, with classical formulations falling under the Ministry of AYUSH. Where it is used in nutraceuticals or food supplements, that use sits under FSSAI. This official pharmacopoeial standing is one reason authenticated Indian material is well documented at origin.

Claims Discipline

Whatever the market, keep the claims honest and lawful. Bhringraj's hair, skin and liver traditions are largely traditional and preclinical, with limited human clinical data. That means no disease claims and no promises of proven human benefit. Where claims are permitted, keep them to supportive, structure/function framing — “supports hair, skin or scalp” — and match the claim to the market's rules. The honest evidence picture is set out in our benefits & research insight.

Documentation Per Market

Line up the market-appropriate documentation with every lot:

• Botanical identity — confirming Eclipta prostrata, not the yellow-flowered Wedelia substitute (see the sourcing guide).
• Heavy metals — Pb, As, Cd, Hg by ICP-MS.
• Pesticide residues — to destination MRLs (essential for the EU).
• Microbiology — total plate count, yeast & mould, pathogens absent.
• ETO — tested on request for EU shipments.
• Batch CoA — referencing a named specification with real results, per the buyer's guide.

To specify the finished material for your market, see the Bhringraj Extract product page.